Volume 29; Issue 7

Nature Biotechnology

Volume 29; Issue 7
2

Psoriasis: from bed to bench and back

Year:
2011
Language:
english
File:
PDF, 391 KB
english, 2011
4

In this issue

Year:
2011
Language:
english
File:
PDF, 488 KB
english, 2011
5

RNA-Seq unleashed

Year:
2011
Language:
english
File:
PDF, 176 KB
english, 2011
10

Streamlining biomarker discovery

Year:
2011
Language:
english
File:
PDF, 262 KB
english, 2011
12

In defense of life sciences venture investing

Year:
2011
Language:
english
File:
PDF, 570 KB
english, 2011
14

New Merck and Vertex drugs raise standard of care in hepatitis C

Year:
2011
Language:
english
File:
PDF, 396 KB
english, 2011
15

Optimer resurrects C. difficile antibiotic to win approval

Year:
2011
Language:
english
File:
PDF, 195 KB
english, 2011
16

Industry access to the literature

Year:
2011
Language:
english
File:
PDF, 117 KB
english, 2011
17

Achieving better healthcare through diverse leadership

Year:
2011
Language:
english
File:
PDF, 121 KB
english, 2011
18

Research highlights

Year:
2011
Language:
english
File:
PDF, 99 KB
english, 2011
19

New self-reporting for GM crops

Year:
2011
Language:
english
File:
PDF, 95 KB
english, 2011
20

Recent patent applications in sequencing and diagnostics

Year:
2011
Language:
english
File:
PDF, 52 KB
english, 2011
21

Avastin as good as Lucentis

Year:
2011
Language:
english
File:
PDF, 108 KB
english, 2011
22

Members need only apply

Year:
2011
Language:
english
File:
PDF, 112 KB
english, 2011
24

Life sciences firms cheer unlocking of National Health Service

Year:
2011
Language:
english
File:
PDF, 108 KB
english, 2011
25

Amgen's Brazilian buying spree

Year:
2011
Language:
english
File:
PDF, 95 KB
english, 2011
27

Alkermes, Elan in $960 million merger

Year:
2011
Language:
english
File:
PDF, 117 KB
english, 2011
28

French bioethics turmoil

Year:
2011
Language:
english
File:
PDF, 108 KB
english, 2011
29

People

Year:
2011
Language:
english
File:
PDF, 102 KB
english, 2011
30

Next-generation flow cytometry

Year:
2011
Language:
english
File:
PDF, 259 KB
english, 2011
31

Teva hits bull's eye with Cephalon

Year:
2011
Language:
english
File:
PDF, 95 KB
english, 2011
32

Gates eyes biotechs as for-profit investments

Year:
2011
Language:
english
File:
PDF, 117 KB
english, 2011
33

Biotechs follow big pharma lead back into academia

Year:
2011
Language:
english
File:
PDF, 296 KB
english, 2011
34

Public biotech 2010—the numbers

Year:
2011
Language:
english
File:
PDF, 488 KB
english, 2011
35

Scant evidence supports EPA's pyramided Bt corn refuge size of 5%

Year:
2011
Language:
english
File:
PDF, 118 KB
english, 2011
36

Biologic Indian detour adds value

Year:
2011
Language:
english
File:
PDF, 95 KB
english, 2011